M3814
Showing 1 - 25 of 84
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Biospecimen
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Biopsy
- +6 more
- (no location specified)
Jan 14, 2023
Neuroendocrine Tumor Trial in United States (Lutetium Lu 177 Dotatate, Peposertib)
Recruiting
- Neuroendocrine Neoplasm
- Biospecimen Collection
- +4 more
-
Duarte, California
- +3 more
Jan 12, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Lymph Nodes, Metastatic Prostate Carcinoma Trial in
Recruiting
- Castration-Resistant Prostate Carcinoma
- +3 more
- Avelumab
- +4 more
-
Los Angeles, California
- +22 more
Feb 2, 2023
Metastatic Leiomyosarcoma, Metastatic Sarcoma, Metastatic Soft Tissue Sarcoma Trial (Computed Tomography, Magnetic Resonance
Not yet recruiting
- Metastatic Leiomyosarcoma
- +5 more
- Computed Tomography
- +3 more
- (no location specified)
Feb 2, 2023
Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in
Recruiting
- Fallopian Tube Carcinosarcoma
- +28 more
- Pegylated Liposomal Doxorubicin Hydrochloride
- Peposertib
-
Aurora, Colorado
- +7 more
Sep 2, 2022
Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous
Suspended
- Advanced Head and Neck Squamous Cell Carcinoma
- +17 more
- Intensity-Modulated Radiation Therapy
- Peposertib
-
Gilbert, Arizona
- +19 more
Dec 31, 2022
Locally Advanced Pancreatic Adenocarcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer
Recruiting
- Locally Advanced Pancreatic Adenocarcinoma
- +6 more
- Hypofractionated Radiation Therapy
- +2 more
-
Duarte, California
- +29 more
Apr 2, 2022
Advanced Solid Tumors Trial in Worldwide (MSC2490484A (M3814), Fractionated RT, Cisplatin)
Completed
- Advanced Solid Tumors
- MSC2490484A (M3814)
- +2 more
-
Fresno, California
- +25 more
Apr 6, 2022
Glioblastoma, Gliosarcoma Trial in Houston (drug, radiation, procedure)
Recruiting
- Glioblastoma
- Gliosarcoma
- Nedisertib
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Sep 27, 2022
Locally Advanced Rectal Cancer Trial in Spain, United States (Peposertib 50 mg, Peposertib 100 mg, Peposertib 150 mg)
Completed
- Locally Advanced Rectal Cancer
- Peposertib 50 mg
- +5 more
-
Aurora, Colorado
- +13 more
Jun 9, 2022
Advanced Solid Tumors, Chronic Lymphocytic Leukemia Trial in Belgium, Denmark, Netherlands (MSC2490484A (M3814))
Completed
- Advanced Solid Tumors
- Chronic Lymphocytic Leukemia
- MSC2490484A (M3814)
-
Bruxelles, Belgium
- +6 more
Apr 24, 2020
Small Cell Lung Cancer Trial in Worldwide (M3814, Cisplatin, Etoposide)
Terminated
- Small Cell Lung Cancer
- M3814
- +2 more
-
Mesa, Arizona
- +79 more
Sep 11, 2020
HIV Trial in Worldwide (GSK3640254, ABC/3TC, FTC/TAF)
Active, not recruiting
- HIV Infections
- GSK3640254
- +4 more
-
Los Angeles, California
- +65 more
Jul 18, 2022
Post-herpetic Neuralgia Trial in Worldwide (EMA401, Placebo)
Terminated
- Post-herpetic Neuralgia
- EMA401
- Placebo
-
Melbourne, Victoria, Australia
- +57 more
Oct 7, 2021
Arthritis, Psoriatic Trial in Worldwide (Guselkumab 100 mg, Placebo)
Completed
- Arthritis, Psoriatic
- Guselkumab 100 mg
- Placebo
-
Brussels, Belgium
- +116 more
Nov 29, 2021
Nasal Polyps, Chronic Rhinosinusitis Trial in Worldwide (Omalizumab, Placebo)
Completed
- Nasal Polyps
- Chronic Rhinosinusitis
- Omalizumab
- Placebo
-
Birmingham, Alabama
- +78 more
Mar 31, 2022
Non Cystic Fibrosis Bronchiectasis Trial in Worldwide (Colistimethate Sodium, Saline Solution)
Completed
- Non Cystic Fibrosis Bronchiectasis
- Colistimethate Sodium
- Saline Solution
-
Adelaide, Australia
- +84 more
Aug 3, 2021
Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF) Trial in
Recruiting
- Primary Myelofibrosis (PMF)
- +2 more
- KRT-232
- Best Available Therapy (BAT)
-
Birmingham, Alabama
- +155 more
Aug 12, 2022
Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)
Recruiting
- Non-Cystic Fibrosis Bronchiectasis
- Brensocatib 10 mg
- +2 more
-
Birmingham, Alabama
- +416 more
Jan 24, 2023
Lung Diseases, Interstitial Trial in Worldwide (Pirfenidone, Placebo)
Completed
- Lung Diseases, Interstitial
- Pirfenidone
- Placebo
-
Camperdown, New South Wales, Australia
- +65 more
Dec 22, 2020
Non Alcoholic Steatohepatitis (NASH) Trial in Worldwide (Obeticholic Acid, Placebo)
Active, not recruiting
- Non Alcoholic Steatohepatitis (NASH)
- Obeticholic Acid
- Placebo
-
Birmingham, Alabama
- +345 more
Jan 24, 2023
Multiple Sclerosis Trial in Worldwide (ponesimod, teriflunomide)
Completed
- Multiple Sclerosis
-
Carlsbad, California
- +161 more
Jan 24, 2022
Glomerular Disease, Proteinuria Trial in Australia, Georgia, United States (ANG-3070, Placebo)
Recruiting
- Glomerular Disease
- Proteinuria
- ANG-3070
- Placebo
-
Birmingham, Alabama
- +29 more
Mar 22, 2022
Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston
Recruiting
- Metastatic Malignant Solid Neoplasm
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2021